BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2018
View Archived Issues
Researchers present gene therapy for methamphetamine-induced inflammation
Read More
Patient recruitment ongoing in phase II/III trial of relatlimab plus nivolumab in melanoma
Read More
Duke University patents mitochondrial antiviral-signaling protein compositions
Read More
Orion Pharma enrolls participants in first-in-human study of ODM-208
Read More
Achaogen receives funds to support development of aminoglycoside antibiotics
Read More
Positive outcome of interim analysis of STRIDE-1 study of AXS-05
Read More
Asavi presents inhibitors of HCV NS5B polymerase, HBV DNA polimerase and HIV-1 reverse transcriptase
Read More
Novel STAT5 inhibitors synthesized at Freie Universitaet Berlin
Read More
AbbVie, Galapagos discover new CFTR modulators
Read More
Oppilotech awarded grant for bacterial cell wall model
Read More
U.S. Department of Health & Human Services, Codagenix patent novel RSV vaccine
Read More
Amgen profiles pipeline progress of first quarter 2018
Read More
Venglustat shows favorable safety and tolerability and biologic activity in healthy volunteers
Read More
New phase II trial studies ISA-101 with utomilumab for HPV16-positive oropharyngeal cancer
Read More
FDA grants breakthrough therapy designation to OMS-721 for HSCT thrombotic microangiopathy
Read More
Vertex initiates phase III studies of VX-445, tezacaftor and ivacaftor in cystic fibrosis
Read More
DNAJC15 expression linked to NAFLD pathogenesis
Read More
Onxeo initiates phase I study of intravenous AsiDNA in advanced solid cancers
Read More
Neuraltus' NP-001 safe and well tolerated but does not slow disease progression in ALS
Read More
Lupus Research Alliance collaborates with Bristol-Myers Squibb to study BMS-986165 for lupus
Read More
ThromboGenics initiates phase II trial of THR-317 with Lucentis for DME
Read More
Proteus Digital Health expands digital medicine pipeline into oncology
Read More
Fujirebio, Janssen enter agreement to develop amyloid beta 42/40 ratio assay
Read More
Tusk Therapeutics' TSK-011010 described as best-in-class anti-CD38 antibody
Read More
MSD applies to expand approval of Keytruda in Japan
Read More
ZED-1227 begins phase IIa study in patients with celiac disease
Read More
Bristol-Myers Squibb updates key milestones of first quarter 2018
Read More
Ono files for Japanese approval of metyrosine for patients with pheochromocytoma
Read More
Chugai files in Japan for Hemlibra for hemophilia A without inhibitors and to extend dosing interval
Read More